I have a lot of questions regarding covid investig
Post# of 72440
(Total Views: 422)
Posted On: 04/22/2020 5:36:07 PM
I have a lot of questions regarding covid investigations/trials of possible treatments and vaccines and just how things tie together. My statements are based on how I interpret things currently and since I am no trained medical person I could be way off. If so, those with knowledge please correct as they know things truly to be:
1 - We have RBLs, University, and Private Corporation (BPs) investigational bodies looking at CV19 to try and come up with answers, but how do these bodies interact (if they interact at all)? How do they divide responsibilities so that many are not looking at the same questions and simply duplicating work already performed? Are these bodies to be viewed like members of a team all pulling for the same result, the greater good, or like mineral prospectors each hoarding their own little batch of information tightly so some other unit doesn't come along and use their data to solve the answer and thus rob them of the glory?
Bottom line, is VP Pence's team the manager of this effort, is it the NIH, a combo of both, or other? I worry it is a major clusterF... Govt hasn't done much good in managing other areas so medicine shouldn't be any different. Not being political here, just govt in general.
2- Who is paying for these investigations? I have assumed a TON of money has already been given to each of the investigational segments listed above for their work. But then I ask, if the BPs are getting paid to further investigate and try and repurpose their already approved drugs for CV19, how do they account for monies spent or is it considered "their" money once they receive it from the govt? If this is so, why weren't they already looking into these drugs years earlier if they really thought they would work as vaccines against pandemics? IMO kind of like throwing money at cucumber farmers to see if they can repurpose cucumbers to fuel jet aircraft or further miniaturize and speed up microchips. That is why I feel the repurposing of current drugs for other means another ploy of govt to piss tax money down the drain and feed their corporate sponsors (BPs) who know the chances of coming up with something spectacular are about nil. I also know IPIX hasn't seen a dime yet, but BPs have been funded so they have some capital with which to proceed.
Now, if BPs are doing their own advanced investigations on their own products, what are the RBLs investigating? The start up biotech products or every other drug under the sun? They have already looked at over 11K drugs per recent PR and Boston U lab said they would screen over 20K drugs. IMO akin to going to all the shoe stores in the world to find suitable boots for a landing on Mars. 99.99% could be shit-canned immediately as unsuitable so testing them all just a waste of time. So in all seriousness, what are the RBL's spending most of their time on? Recent PR said they only had about 30 drugs to date that showed any possible progress in solving the CV19 problem so it doesn't look like enough drugs to go around to keep all RBL's busy. And contrary to many, I don't feel Brilacidin has been given ANY favors in being put at the head of the line at these labs. To me it doesn't look like bosses truly understand the power of the drug so it stays in line like every other drug that is viewed as a "very remote" possibility.
That leaves University labs, here I am at a loss as to just how they fit in as to feedback to the govt and their ability to tackle any problem quickly. They are academia, that is the antithesis to speed and results. I look at them as "milk 'em as long as we can" labs.
How long does it take to do a human lung tissue test?
Why was IPIX, per recent PR, looking for hospitals and healthcare systems to do a possible trial of Brilacidin on human patients - doesn't the government have power to tell any hospital they want to test this product if they want them to do it? Wouldn't EVERY hospital in America jump at a chance to test ANY possible treatment that could reduce their death toll, so what the hell is IPIX sent out to find a trial site?
Same questions as above as to IPIX finding a source to make enough Brilacidin to run the human test. Who the hell is running the ship on CV? I certainly didn't think it was IPIX. God help us if a one man operation is the best we can do to source product and trial site for what appears to be possibly the most well rounded answer to the CV crisis!!
I will stop here. Again, I stress I may be way off and my assumptions may be way off as to what is currently happening, that is why I post and hope to get feedback on what others think.
1 - We have RBLs, University, and Private Corporation (BPs) investigational bodies looking at CV19 to try and come up with answers, but how do these bodies interact (if they interact at all)? How do they divide responsibilities so that many are not looking at the same questions and simply duplicating work already performed? Are these bodies to be viewed like members of a team all pulling for the same result, the greater good, or like mineral prospectors each hoarding their own little batch of information tightly so some other unit doesn't come along and use their data to solve the answer and thus rob them of the glory?
Bottom line, is VP Pence's team the manager of this effort, is it the NIH, a combo of both, or other? I worry it is a major clusterF... Govt hasn't done much good in managing other areas so medicine shouldn't be any different. Not being political here, just govt in general.
2- Who is paying for these investigations? I have assumed a TON of money has already been given to each of the investigational segments listed above for their work. But then I ask, if the BPs are getting paid to further investigate and try and repurpose their already approved drugs for CV19, how do they account for monies spent or is it considered "their" money once they receive it from the govt? If this is so, why weren't they already looking into these drugs years earlier if they really thought they would work as vaccines against pandemics? IMO kind of like throwing money at cucumber farmers to see if they can repurpose cucumbers to fuel jet aircraft or further miniaturize and speed up microchips. That is why I feel the repurposing of current drugs for other means another ploy of govt to piss tax money down the drain and feed their corporate sponsors (BPs) who know the chances of coming up with something spectacular are about nil. I also know IPIX hasn't seen a dime yet, but BPs have been funded so they have some capital with which to proceed.
Now, if BPs are doing their own advanced investigations on their own products, what are the RBLs investigating? The start up biotech products or every other drug under the sun? They have already looked at over 11K drugs per recent PR and Boston U lab said they would screen over 20K drugs. IMO akin to going to all the shoe stores in the world to find suitable boots for a landing on Mars. 99.99% could be shit-canned immediately as unsuitable so testing them all just a waste of time. So in all seriousness, what are the RBL's spending most of their time on? Recent PR said they only had about 30 drugs to date that showed any possible progress in solving the CV19 problem so it doesn't look like enough drugs to go around to keep all RBL's busy. And contrary to many, I don't feel Brilacidin has been given ANY favors in being put at the head of the line at these labs. To me it doesn't look like bosses truly understand the power of the drug so it stays in line like every other drug that is viewed as a "very remote" possibility.
That leaves University labs, here I am at a loss as to just how they fit in as to feedback to the govt and their ability to tackle any problem quickly. They are academia, that is the antithesis to speed and results. I look at them as "milk 'em as long as we can" labs.
How long does it take to do a human lung tissue test?
Why was IPIX, per recent PR, looking for hospitals and healthcare systems to do a possible trial of Brilacidin on human patients - doesn't the government have power to tell any hospital they want to test this product if they want them to do it? Wouldn't EVERY hospital in America jump at a chance to test ANY possible treatment that could reduce their death toll, so what the hell is IPIX sent out to find a trial site?
Same questions as above as to IPIX finding a source to make enough Brilacidin to run the human test. Who the hell is running the ship on CV? I certainly didn't think it was IPIX. God help us if a one man operation is the best we can do to source product and trial site for what appears to be possibly the most well rounded answer to the CV crisis!!
I will stop here. Again, I stress I may be way off and my assumptions may be way off as to what is currently happening, that is why I post and hope to get feedback on what others think.
(3)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼